Loading...

Braskem

BME:XBRK
Snowflake Description

Undervalued with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
XBRK
BME
R$28B
Market Cap
  1. Home
  2. ES
  3. Materials
Company description

Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The last earnings update was 45 days ago. More info.


Add to Portfolio Compare Print
  • Braskem has significant price volatility in the past 3 months.
XBRK Share Price and Events
7 Day Returns
0%
BME:XBRK
2%
Europe Chemicals
0.7%
ES Market
1 Year Returns
-27.7%
BME:XBRK
-4.5%
Europe Chemicals
-4%
ES Market
XBRK Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Braskem (XBRK) 0% -11% -28.9% -27.7% 88.3% 72.4%
Europe Chemicals 2% 3.5% 2.1% -4.5% 27.9% 18.8%
ES Market 0.7% 0.5% 0.5% -4% 22.2% -17.1%
1 Year Return vs Industry and Market
  • XBRK underperformed the Chemicals industry which returned -4.5% over the past year.
  • XBRK underperformed the Market in Spain which returned -4% over the past year.
Price Volatility
XBRK
Industry
5yr Volatility vs Market

XBRK Value

 Is Braskem undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Braskem to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Braskem.

BME:XBRK Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.3%
Perpetual Growth Rate 10-Year ES Government Bond Rate 1.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BME:XBRK
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year ES Govt Bond Rate 1.5%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.88
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.875 (1 + (1- 34%) (141.65%))
1.465
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.46
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.53% + (1.465 * 5.96%)
10.26%

Discounted Cash Flow Calculation for BME:XBRK using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Braskem is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BME:XBRK DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (BRL, Millions) Source Present Value
Discounted (@ 10.26%)
2019 -2,916.00 Analyst x1 -2,644.74
2020 2,706.00 Analyst x1 2,225.96
2021 4,906.00 Analyst x1 3,660.27
2022 5,390.71 Est @ 9.88% 3,647.76
2023 5,788.20 Est @ 7.37% 3,552.38
2024 6,113.46 Est @ 5.62% 3,402.97
2025 6,381.93 Est @ 4.39% 3,221.94
2026 6,607.33 Est @ 3.53% 3,025.42
2027 6,800.92 Est @ 2.93% 2,824.38
2028 6,971.55 Est @ 2.51% 2,625.91
Present value of next 10 years cash flows R$25,542.24
BME:XBRK DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= R$6,971.55 × (1 + 1.53%) ÷ (10.26% – 1.53%)
R$81,069.52
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= R$81,069.52 ÷ (1 + 10.26%)10
R$30,535.70
BME:XBRK Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= R$25,542.24 + R$30,535.70
R$56,077.94
Equity Value per Share
(BRL)
= Total value / Shares Outstanding
= R$56,077.94 / 795.73
R$70.47
BME:XBRK Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BME:XBRK represents 0.22695x of BOVESPA:BRKM5
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.22695x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (BRL) x Listing Adjustment Factor
= R$ 70.47 x 0.22695
€15.99
Value per share (EUR) From above. €15.99
Current discount Discount to share price of €8.10
= -1 x (€8.10 - €15.99) / €15.99
49.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Braskem is available for.
Intrinsic value
49%
Share price is €8.1 vs Future cash flow value of €15.99
Current Discount Checks
For Braskem to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Braskem's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Braskem's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Braskem's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Braskem's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BME:XBRK PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in BRL R$3.57
BOVESPA:BRKM5 Share Price ** BOVESPA (2019-06-25) in BRL R$35.69
Europe Chemicals Industry PE Ratio Median Figure of 91 Publicly-Listed Chemicals Companies 17.73x
Spain Market PE Ratio Median Figure of 139 Publicly-Listed Companies 16.9x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Braskem.

BME:XBRK PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BOVESPA:BRKM5 Share Price ÷ EPS (both in BRL)

= 35.69 ÷ 3.57

10x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Braskem is good value based on earnings compared to the Europe Chemicals industry average.
  • Braskem is good value based on earnings compared to the Spain market.
Price based on expected Growth
Does Braskem's expected growth come at a high price?
Raw Data
BME:XBRK PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 10x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
26.9%per year
Europe Chemicals Industry PEG Ratio Median Figure of 60 Publicly-Listed Chemicals Companies 1.93x
Spain Market PEG Ratio Median Figure of 80 Publicly-Listed Companies 1.63x

*Line of best fit is calculated by linear regression .

BME:XBRK PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 10x ÷ 26.9%

0.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Braskem is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Braskem's assets?
Raw Data
BME:XBRK PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in BRL R$10.14
BOVESPA:BRKM5 Share Price * BOVESPA (2019-06-25) in BRL R$35.69
Europe Chemicals Industry PB Ratio Median Figure of 140 Publicly-Listed Chemicals Companies 1.72x
Spain Market PB Ratio Median Figure of 185 Publicly-Listed Companies 1.68x
BME:XBRK PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BOVESPA:BRKM5 Share Price ÷ Book Value per Share (both in BRL)

= 35.69 ÷ 10.14

3.52x

* Primary Listing of Braskem.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Braskem is overvalued based on assets compared to the Europe Chemicals industry average.
X
Value checks
We assess Braskem's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Braskem has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

XBRK Future Performance

 How is Braskem expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
26.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Braskem expected to grow at an attractive rate?
  • Braskem's earnings growth is expected to exceed the low risk savings rate of 1.5%.
Growth vs Market Checks
  • Braskem's earnings growth is expected to exceed the Spain market average.
  • Braskem's revenue growth is positive but not above the Spain market average.
Annual Growth Rates Comparison
Raw Data
BME:XBRK Future Growth Rates Data Sources
Data Point Source Value (per year)
BME:XBRK Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 26.9%
BME:XBRK Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 3.8%
Europe Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 10.6%
Europe Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.9%
Spain Market Earnings Growth Rate Market Cap Weighted Average 7.9%
Spain Market Revenue Growth Rate Market Cap Weighted Average 4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BME:XBRK Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in BRL Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BME:XBRK Future Estimates Data
Date (Data in BRL Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 66,735 4,776 1
2021-12-31 59,030 6,800 3,287 5
2020-12-31 58,693 5,157 2,649 6
2019-12-31 54,821 2,468 863 5
BME:XBRK Past Financials Data
Date (Data in BRL Millions) Revenue Cash Flow Net Income *
2019-03-31 57,949 8,494 2,841
2018-12-31 58,000 9,250 2,867
2018-09-30 55,792 9,572 3,331
2018-06-30 51,605 8,930 2,786
2018-03-31 49,690 3,694 3,329
2017-12-31 49,261 2,462 4,074
2017-09-30 48,678 2,403 1,153
2017-06-30 48,498 3,293 1,238
2017-03-31 48,349 4,778 548
2016-12-31 47,664 4,458 -438
2016-09-30 47,547 5,284 2,188
2016-06-30 48,729 5,946 2,870

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Braskem's earnings are expected to grow significantly at over 20% yearly.
  • Braskem's revenue is expected to grow by 3.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BME:XBRK Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Braskem Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BME:XBRK Future Estimates Data
Date (Data in BRL Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 5.99 5.99 5.99 1.00
2021-12-31 5.24 8.91 2.47 4.00
2020-12-31 4.05 4.88 2.89 4.00
2019-12-31 2.03 2.67 0.92 3.00
BME:XBRK Past Financials Data
Date (Data in BRL Millions) EPS *
2019-03-31 3.57
2018-12-31 3.60
2018-09-30 4.19
2018-06-30 3.50
2018-03-31 4.18
2017-12-31 5.12
2017-09-30 1.45
2017-06-30 1.56
2017-03-31 0.69
2016-12-31 -0.55
2016-09-30 2.75
2016-06-30 3.61

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Braskem is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Braskem's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Braskem has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

XBRK Past Performance

  How has Braskem performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Braskem's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Braskem's year on year earnings growth rate has been positive over the past 5 years.
  • Braskem's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Braskem's 1-year earnings growth is negative, it can't be compared to the Europe Chemicals industry average.
Earnings and Revenue History
Braskem's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Braskem Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BME:XBRK Past Revenue, Cash Flow and Net Income Data
Date (Data in BRL Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 57,949.02 2,840.66 3,328.60 209.87
2018-12-31 57,999.87 2,866.68 3,178.57 199.82
2018-09-30 55,791.57 3,331.33 3,029.78 195.22
2018-06-30 51,605.46 2,786.43 2,923.63 180.99
2018-03-31 49,689.67 3,329.03 2,913.36 172.72
2017-12-31 49,260.59 4,074.11 2,893.88 167.46
2017-09-30 48,678.32 1,153.08 2,834.55 153.15
2017-06-30 48,497.61 1,238.10 2,780.99 151.53
2017-03-31 48,349.12 547.84 2,754.14 153.08
2016-12-31 47,663.99 -438.33 2,689.29 162.01
2016-09-30 47,547.15 2,187.66 2,562.62 169.61
2016-06-30 48,729.43 2,870.33 2,479.62 170.11
2016-03-31 48,599.26 3,556.44 2,396.62 172.41
2015-12-31 46,879.99 2,995.34 2,363.63 169.64
2015-09-30 46,562.41 2,965.44 2,384.40 156.98
2015-06-30 45,122.75 1,667.39 2,369.26 153.58
2015-03-31 44,384.09 710.16 2,380.42 144.12
2014-12-31 46,031.39 864.06 2,365.92 138.44
2014-09-30 45,202.77 812.02 2,259.06 138.00
2014-06-30 44,416.81 941.56 2,195.66 131.59
2014-03-31 43,310.95 699.00 2,117.81 125.39
2013-12-31 40,969.49 509.70 2,078.68 115.81
2013-09-30 40,064.89 466.63 2,162.63 105.65
2013-06-30 38,381.08 -13.97 2,112.72 106.08
2013-03-31 37,589.82 -940.14 2,114.10 106.32
2012-12-31 36,160.33 -1,012.69 2,061.39 106.20
2012-09-30 34,313.09 -1,203.14 1,782.25 110.23
2012-06-30 33,744.83 -2,171.89 1,764.56 106.69

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Whilst Braskem has efficiently used shareholders’ funds last year (Return on Equity greater than 20%), this is metric is skewed due to its high level of debt.
  • Braskem used its assets more efficiently than the Europe Chemicals industry average last year based on Return on Assets.
  • Braskem's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Braskem's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Braskem has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

XBRK Health

 How is Braskem's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Braskem's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Braskem's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Braskem's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Braskem's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Braskem Company Filings, last reported 2 months ago.

BME:XBRK Past Debt and Equity Data
Date (Data in BRL Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 7,194.37 38,081.29 7,840.20
2018-12-31 5,911.25 37,881.09 7,926.25
2018-09-30 6,411.66 38,733.11 6,971.88
2018-06-30 4,848.52 38,937.74 7,222.00
2018-03-31 7,336.11 33,599.07 5,853.51
2017-12-31 5,690.35 35,129.67 6,077.77
2017-09-30 7,002.44 34,101.93 7,314.21
2017-06-30 5,740.02 36,340.02 7,948.70
2017-03-31 4,534.00 34,962.88 7,206.43
2016-12-31 1,720.71 36,279.72 7,462.54
2016-09-30 4,393.85 36,165.43 8,200.87
2016-06-30 4,873.84 36,610.19 6,760.35
2016-03-31 3,642.06 39,573.57 7,536.10
2015-12-31 945.49 42,342.17 7,470.77
2015-09-30 1,643.75 43,225.89 6,464.70
2015-06-30 4,616.25 34,304.17 4,943.24
2015-03-31 3,499.19 34,486.27 5,180.72
2014-12-31 5,894.35 29,362.11 4,116.64
2014-09-30 7,515.21 27,231.33 3,851.09
2014-06-30 8,361.07 23,699.54 3,338.34
2014-03-31 8,379.25 23,165.70 3,339.49
2013-12-31 7,681.33 24,121.11 4,451.06
2013-09-30 8,174.79 21,867.13 3,916.90
2013-06-30 7,890.61 19,310.38 3,439.50
2013-03-31 8,873.63 18,345.71 3,224.00
2012-12-31 8,651.98 17,803.22 3,459.77
2012-09-30 8,556.17 17,270.37 3,810.84
2012-06-30 8,698.44 16,906.41 3,468.06
  • Braskem's level of debt (529.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (276.5% vs 529.3% today).
  • Debt is well covered by operating cash flow (22.3%, greater than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 2.8x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Braskem's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Braskem has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

XBRK Dividends

 What is Braskem's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Braskem dividends. Estimated to be 4.7% next year.
If you bought €2,000 of Braskem shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Braskem's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Braskem's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BME:XBRK Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Europe Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 76 Stocks 3.1%
Spain Market Average Dividend Yield Market Cap Weighted Average of 77 Stocks 4.4%
Spain Minimum Threshold Dividend Yield 10th Percentile 1.3%
Spain Bottom 25% Dividend Yield 25th Percentile 2.2%
Spain Top 25% Dividend Yield 75th Percentile 5.2%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BME:XBRK Future Dividends Estimate Data
Date (Data in R$) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 3.00 1.00
2021-12-31 1.69 4.00
2020-12-31 1.75 4.00
2019-12-31 0.85 2.00
BME:XBRK Past Annualized Dividends Data
Date (Data in R$) Dividend per share (annual) Avg. Yield (%)
2019-05-13 0.000 0.000
2019-03-14 0.000 0.000
2019-03-12 0.000 0.000
2018-05-02 3.142 6.081
2017-11-09 2.513 5.398
2016-04-06 2.514 8.982
2015-04-09 0.606 3.515
2014-02-14 0.606 4.015
2014-02-13 0.606 3.180
2013-02-07 0.000 0.000
2012-08-14 0.605 4.318
2012-03-27 0.605 4.776
2012-03-14 0.605 4.006
2011-05-03 0.833 5.052
2009-11-10 0.000 0.000
2009-11-03 0.000 0.000
2009-08-12 0.000 0.000
2009-05-06 0.000 0.000
2009-03-05 0.000 0.000
2008-06-30 0.645 8.271

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Braskem has not reported any payouts.
  • Unable to verify if Braskem's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Braskem's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Braskem has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Braskem's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Braskem afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Braskem has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

XBRK Management

 What is the CEO of Braskem's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Fernando Musa
AGE 53
TENURE AS CEO 3.1 years
CEO Bio

Mr. Fernando Musa has been the Chief Executive Officer of Braskem S.A. since May 2016. Mr. Musa has been the Chief Executive Officer of Braskem America, Inc. since April 2012. He served as Head of United States and Europe Unit at Braskem S.A. until May 2016. He served as Vice President of Planning, Purchasing , Business Development & Information Technology at Braskem S.A. Previously, he was responsible for the integration of Quattor (a Brazilian chemical and petrochemical company) after its acquisition by Braskem in 2010. He has a wealth of business experience and knowledge. He worked for 22 years at companies as diverse as Monitor Group as Managing Partner, MGDK as Founding Partner, Editora Abril, McKinsey and Dow Chemical. While with McKinsey, he worked in both Mexico and France. Mr. Musa is a graduate of Instituto Tecnologico de Aeronautica (ITA) in Sao Jose dos Campos, Brazil, with a degree in Mechanical Engineering and also received his MBA from INSEAD in France.

CEO Compensation
  • Insufficient data for Fernando to compare compensation growth.
  • Insufficient data for Fernando to establish whether their remuneration is reasonable compared to companies of similar size in Spain.
Management Team Tenure

Average tenure and age of the Braskem management team in years:

2.8
Average Tenure
50
Average Age
  • The tenure for the Braskem management team is about average.
Management Team

Fernando Musa

TITLE
Chief Executive Officer
AGE
53
TENURE
3.1 yrs

Pedro van Langendonck Teixeira de Freitas

TITLE
VP Executive Officer
AGE
43
TENURE
3.3 yrs

Gustavo Valverde

TITLE
VP Executive Officer
AGE
43

Everson Bassinello

TITLE
Chief Compliance Officer
TENURE
2.8 yrs

André Vieira

TITLE
Director of Corporate Communication

Marcelo De Carvalho

TITLE
Head of People
AGE
50

Marcelo de Oliveira Cerqueira

TITLE
Head of the Chemicals & Vinyl Unit
AGE
53
TENURE
2.2 yrs

Roberto Bischoff

TITLE
Head of Competitiveness

Mark Nikolich

TITLE
Head of the Polyolefins North America Unit
TENURE
1.8 yrs

Mateus Garcez Lopes

TITLE
Head of Innovation for Renewable Technologies
Board of Directors Tenure

Average tenure and age of the Braskem board of directors in years:

2
Average Tenure
58
Average Age
  • The average tenure for the Braskem board of directors is less than 3 years, this suggests a new board.
Board of Directors

Paula Cristina Penteado Azevedo

TITLE
Chairwoman

Ernani Filgueiras de Carvalho

TITLE
Vice Chairman of the Board
AGE
69
TENURE
3.2 yrs

Roberto Lopes Simões

TITLE
Director
AGE
61
TENURE
0.1 yrs

Mauro Figueira

TITLE
Director
AGE
48
TENURE
0.1 yrs

João Neto

TITLE
Director
AGE
54
TENURE
3 yrs

Gesner de Oliveira Filho

TITLE
Independent Director
AGE
62
TENURE
2 yrs

Marcelo Lyrio

TITLE
Independent Director
AGE
55
TENURE
2 yrs

Pedro Sousa

TITLE
Independent Director
AGE
45
TENURE
2 yrs

Fábio Venturelli

TITLE
Director
TENURE
0.7 yrs

Roberto Faldini

TITLE
Director
AGE
69
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Braskem's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Braskem has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

XBRK News

Simply Wall St News

XBRK Company Info

Description

Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through Chemicals, Polyolefins, Vinyls, United States and Europe, and Mexico segments. The Chemicals segment produces and sells ethylene, propylene butadiene, toluene, xylene, cumene, and benzene, as well as gasoline, diesel and liquefied petroleum gas, and other petroleum derivatives; and supplies electric energy, steam, compressed air, and other inputs to second-generation producers. The Polyolefins segment produces and sells polyethylene and polypropylene. The Vinyls segment produces and sells polyvinyl chloride, caustic soda, and chloride. The United States and Europe segment produces and sells polypropylene in the United States and Europe. The Mexico segment produces and sells polyethylene. The company also produces basic petrochemicals; imports and exports chemicals, petrochemicals, and fuels; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil. Braskem S.A. is a subsidiary of Odebrecht S.A.

Details
Name: Braskem S.A.
XBRK
Exchange: BME
Founded: 1972
R$6,465,510,627
795,733,681
Website: http://www.braskem.com.br
Address: Braskem S.A.
Rua Lemos Monteiro, 120,
22º andar,
São Paulo,
São Paulo, 05501-050,
Brazil
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BOVESPA BRKM5 Class A Preferred Shares Bolsa de Valores de Sao Paulo BR BRL 07. Jan 1992
DB BRDA Class A Preferred Shares Deutsche Boerse AG DE EUR 07. Jan 1992
BME XBRK Class A Preferred Shares Bolsas y Mercados Espanoles ES EUR 07. Jan 1992
OTCPK BRKM.Y ADR EA REP 2 PRF'A'NPV Pink Sheets LLC US USD 29. Jan 1993
BOVESPA BRKM6 Class B Preferred Shares Bolsa de Valores de Sao Paulo BR BRL 30. Jun 1993
BOVESPA BRKM3 Common Shares Bolsa de Valores de Sao Paulo BR BRL 26. Mar 1993
DB BRD ADR EA REP 2 PRF'A'NPV Deutsche Boerse AG DE EUR 29. Jan 1993
BMV BAK N ADR EA REP 2 PRF'A'NPV Bolsa Mexicana de Valores MX MXN 29. Jan 1993
Number of employees
Current staff
Staff numbers
0
Braskem employees.
Industry
Commodity Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/26 02:25
End of day share price update: 2019/06/25 00:00
Last estimates confirmation: 2019/06/20
Last earnings filing: 2019/05/12
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.